Related Experiment Video
Updated: Dec 15, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Cell cycle exit during bortezomib-induced osteogenic differentiation of mesenchymal stem cells was mediated by
Dan Zhang1, Rong Fan1, Li Lei1
1Department of Cell Biology and Genetics, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Abstract:
Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into a variety of cell types. Bortezomib, the first approved proteasome inhibitor used for the treatment of multiple myeloma (MM), has been shown to induce osteoblast differentiation, making it beneficial for myeloma bone disease. In the present study, we aimed to investigate the effects and underlying mechanisms of bortezomib on the cell cycle during osteogenic differentiation. We confirmed that low doses of bortezomib can induce MSCs towards osteogenic differentiation, but high doses are toxic. In the course of bortezomib-induced osteogenic differentiation, we observed cell cycle exit characterized by G0 /G1 phase cell cycle arrest with a significant reduction in cell proliferation. Additionally, we found that the cell cycle exit was tightly related to the induction of the cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 . Notably, we further demonstrated that the up-regulation of p21Cip1 and p27Kip1 is transcriptionally dependent on the bortezomib-activated ER stress signalling branch Ire1α/Xbp1s. Taken together, these findings reveal an intracellular pathway that integrates proteasome inhibition, osteogenic differentiation and the cell cycle through activation of the ER stress signalling branch Ire1α/Xbp1s.
Insights
Low doses of bortezomib promote osteogenic differentiation in mesenchymal stem cells (MSCs) by arresting the cell cycle. This process involves ER stress signaling, upregulating key inhibitors like p21 and p27.
Area of Science:
- Cell Biology
- Stem Cell Research
- Pharmacology
Background:
- Mesenchymal stem cells (MSCs) are multipotent and crucial for bone regeneration.
- Bortezomib, a proteasome inhibitor, treats multiple myeloma and aids bone disease by inducing osteoblast differentiation.
- Understanding bortezomib's impact on MSCs' cell cycle during osteogenesis is vital.
Purpose of the Study:
- Investigate bortezomib's effects on the cell cycle during osteogenic differentiation of MSCs.
- Elucidate the molecular mechanisms underlying bortezomib-induced cell cycle changes.
- Explore the role of ER stress signaling in this process.
Main Methods:
- Treatment of MSCs with varying bortezomib doses.
- Analysis of cell cycle progression (G0/G1 arrest).
- Assessment of proliferation rates and expression of cyclin-dependent kinase inhibitors (p21Cip1, p27Kip1).
- Investigation of the ER stress pathway (Ire1α/Xbp1s).
Main Results:
- Low-dose bortezomib induced osteogenic differentiation in MSCs.
- Bortezomib treatment led to G0/G1 cell cycle arrest and reduced proliferation.
- Upregulation of p21Cip1 and p27Kip1 correlated with cell cycle exit.
- This upregulation was dependent on the Ire1α/Xbp1s ER stress pathway.
Conclusions:
- Bortezomib at low doses drives MSC osteogenic differentiation via cell cycle arrest.
- The Ire1α/Xbp1s ER stress pathway mediates bortezomib's effects on cell cycle regulators.
- This pathway links proteasome inhibition, osteogenesis, and cell cycle control.
More Related Videos
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...